Elena Herranz-Bayo

2PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 06, 2026
Pharmacokinetic insights into atezolizumab SC: viability of extended dosing intervals beyond the standard regimen.

Vicente Gimeno-Ballester, Elena Herranz-Bayo, Cristina Trigo-Vicente

|Sep 06, 2024
Lung immune prognostic index (LIPI) as a prognostic factor in patients with extensive-stage small cell lung cancer treated with first-line chemoimmunotherapy.

Elena Herranz-Bayo, Luis Enrique Chara-Velarde, Javier Cassinello-Espinosa

Pageof 1

Frequent Collaborators

2 joint publications

Vicente Gimeno-Ballester

1 joint publications

Luis Enrique Chara-Velarde

1 joint publications

Ángel Artal-Cortés

1 joint publications

Alba Moratiel-Pellitero